AXISCADES Technologies (532395) Q2 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 25/26 earnings summary
20 Oct, 2026Executive summary
Power930 targets INR 9,000 crore ($1 billion) revenue by FY30, shifting toward products, solutions and manufacturing-led growth.
FY26 core-domain revenue growth and overall EBITDA growth targets are 45%; management cited visibility into FY27 and growth above 70% for FY28–FY30.
Financial highlights
Q2 FY26 revenue from operations was INR 29,905.89 lakh, up 13% YoY and 22.7% QoQ; EBITDA was INR 47 crore, up 41.5%, and PAT was INR 2,312.79 lakh, up 88.9%.
Q2 total income was INR 30,500.34 lakh and PBT INR 3,626.18 lakh; both exceeded Q2 FY24.
H1 revenue from operations was INR 54,276.46 lakh, up 11.2%; EBITDA was INR 81 crore, up 25.7%, and PAT was INR 4,398.79 lakh, up 51.6%.
H1 total income was INR 55,930.38 lakh and PBT INR 6,424.02 lakh, up 11.2% and 49.6%, respectively.
Outlook and guidance
Management expects Q3 to be as strong as Q2; relocation may make Q4 steadier, while FY26 growth commitments remain intact.
H2 typically contributes 55% of annual revenue, with defense deliveries weighted toward the second half; management cited a visible order pipeline and expected defense ramp-up.
ESAI growth is expected to remain subdued in Q3 and Q4 as manufacturing capacity is installed and certified; other segments are expected to offset the slowdown.
Latest events from AXISCADES Technologies
- Record Q2 revenue growth offset by lower PAT and margin pressure.532395
Q2 23/24 - Q1 revenue rose 4.5% as Aerospace and Defence drove growth amid uneven demand.532395
Q1 24/25 - Aerospace and Defence led growth as automotive weakness pressured margins.532395
Q2 24/25 - Core-domain growth and investment underpin FY26 EBITDA and margin targets.532395
Q3 24/25 - Core-led growth and product transformation support the $1 billion FY30 revenue target.532395
Q4 24/25 - Core growth and H2 execution support FY26 guidance and Power 930’s $1B FY30 target.532395
Q1 25/26 - Q3 growth and margin gains advanced product-led expansion and 40%+ growth targets.532395
Q3 25/26 - FY26 growth and portfolio reset set up FY27, with deferred-order conversion central.532395
Q4 25/26 - Record revenue and 94.2% continuing growth amid transition costs and a manufacturing-led pivot.532395
Q1 26/27